These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 20705512

  • 1. Rheohaemapheresis.
    Otto J.
    Transfus Apher Sci; 2010 Oct; 43(2):217-22. PubMed ID: 20705512
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rheohaemapheresis of ophthalmological diseases and diseases of the microcirculation.
    Borberg H, Tauchert M.
    Transfus Apher Sci; 2006 Feb; 34(1):41-9. PubMed ID: 16343990
    [Abstract] [Full Text] [Related]

  • 6. Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration.
    Blaha M, Rencova E, Langrova H, Studnicka J, Blaha V, Rozsival P, Lanska M, Sobotka L.
    Atheroscler Suppl; 2013 Jan; 14(1):179-84. PubMed ID: 23357162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration.
    Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B.
    Ther Apher Dial; 2010 Jun; 14(3):276-86. PubMed ID: 20609179
    [Abstract] [Full Text] [Related]

  • 9. Blood levels of antioxidants during age-related macular degeneration treatment by rheohaemapheresis.
    Aufartova J, Blaha M, Kasalova E, Honegrova B, Cervinkova B, Kujovska Krcmova L, Plisek J, Lanska M, Sobotka L, Solichova D.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):400-6. PubMed ID: 26077006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H.
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [Abstract] [Full Text] [Related]

  • 14. [Rheophoresis. A systematic approach to therapy of age-related macular degeneration (AMD)?].
    Fell AJ, Engelmann K, Richard G, Fassbender C, Wahls W, Klingel R.
    Ophthalmologe; 2002 Oct; 99(10):780-4. PubMed ID: 12376854
    [Abstract] [Full Text] [Related]

  • 15. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M, Motz W, Strauer BE.
    Wien Med Wochenschr; 1986 Oct; 136 Spec No():17-24. PubMed ID: 3825169
    [Abstract] [Full Text] [Related]

  • 16. Change in hemorrheological and biochemical parameters following membrane differential filtration.
    Brunner R, Widder RA, Walter P, Borberg H, Oette K.
    Int J Artif Organs; 1995 Dec; 18(12):794-8. PubMed ID: 8964647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes of the complement system and rheological indicators after therapy with rheohemapheresis.
    Blaha M, Andrys C, Langrova H, Studnicka J, Drsata J, Lanska M, Blaha V, Zak P.
    Atheroscler Suppl; 2015 May; 18():140-5. PubMed ID: 25936318
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.